Dagnew, A.F., et al. Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01E-4 tuberculosis vaccine. Vaccine, 2026 Jul 11, 85:128690. PMID: 42119392
This paper presents the design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01E-4 tuberculosis vaccine, which incorporates the AS01 adjuvant system. The primary focus [...]